Slb Pharma Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.35 Cr
as on 24-10-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.26 Cr
as on 24-10-2024
- Revenue -52.01%
(FY 2023)
- Profit 23.96%
(FY 2023)
- Ebitda 29.83%
(FY 2023)
- Net Worth 17.71%
(FY 2023)
- Total Assets -0.85%
(FY 2023)
About Slb Pharma
The Corporate was formerly known as Sri Lakshmi Bhargavi Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 1.35 Cr.
The company currently has active open charges totaling ₹4.26 Cr.
Narendra Kantipudi, Vundavalli Prasad, Mohanaiah Paladi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232TG2007PTC053031
- Company No.
053031
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Mar 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Slb Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohanaiah Paladi  | Director | 10-Aug-2020 | Current |
| Debashish Datta | Director | 10-Aug-2020 | Current |
| Narendra Kantipudi | Director | 15-Nov-2008 | Current |
| Vundavalli Prasad | Director | 18-May-2010 | Current |
| Gurram Subbalakshmi | Director | 10-Aug-2020 | Current |
Financial Performance and Corporate Structure Insights of Slb Pharma.
Slb Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 52.01% decrease. The company also saw a substantial improvement in profitability, with a 23.96% increase in profit. The company's net worth Soared by an impressive increase of 17.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Slb Pharma?
In 2023, Slb Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Telangana Industrial Health Clinic LimitedActive 7 years 6 monthsMohanaiah Paladi is a mutual person
Haritha Laboratories Private LimitedActive 16 years 1 monthNarendra Kantipudi and Gurram Subbalakshmi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 02 May 2024 | ₹2.00 Cr | Open |
Bank Of India Creation Date: 03 Jan 2024 | ₹1.90 M | Open |
Bank Of India Creation Date: 03 Jan 2024 | ₹1.00 M | Open |
How Many Employees Work at Slb Pharma?
Slb Pharma has a workforce of 15 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Slb Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Slb Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
